COPD-asthma market to reach $47bn in 2017 – PMLiVE


AARP News

COPD-asthma market to reach $47bn in 2017
PMLiVE
The global market for asthma and chronic obstructive pulmonary disease (COPD) drugs is set to reach $47bn in 2017 according to a new report. US market research firm BCC Research estimates that the market for prescription drugs in these respiratory
Global Markets for Asthma, COPD Drugs to Hit $47 Billion in 2017news Stories
Meet held to discuss respiratory diseasesThe Hindu
Global Markets for Asthma & COPD Drugs to hit $47 Billion in 2017MarketWatch (press release)

all 15 news articles »

View full post on asthma – Google News

‘Report Predicts Asthma and COPD Drug Revenues Will Reach $43.8BN in 2015 … – PR Newswire UK (press release)

'Report Predicts Asthma and COPD Drug Revenues Will Reach $43.8BN in 2015
PR Newswire UK (press release)
A new report by visiongain, a London-based business information company, predicts that world asthma and COPD drug revenues will reach $43.8bnin 2015. That market generated $32.1bn in 2010, according to Asthma and COPD Therapies: World Market 2011-2021,

and more »

View full post on asthma – Google News

‘Report Predicts Asthma And COPD Drug Revenues Will Reach $43.8BN In 2015 … – Science 2.0 (press release)

'Report Predicts Asthma And COPD Drug Revenues Will Reach $43.8BN In 2015
Science 2.0 (press release)
A new report by visiongain, a London-based business information company, predicts that world asthma and COPD drug revenues will reach $43.8bnin 2015. That market generated $32.1bn in 2010, according to Asthma and COPD Therapies: World Market 2011-2021,

and more »

View full post on asthma – Google News